Literature DB >> 23104093

The insulin receptor and the kidney.

Lorna J Hale1, Richard J M Coward.   

Abstract

PURPOSE OF REVIEW: In recent years, it has become clear that the insulin receptor is important in a variety of renal cell types. It is through this transmembrane receptor that insulin, and to a lesser extent insulin-like growth factor, hormones bind and can control important cellular functions. This review will summarize the advances in our understanding of the role of the insulin receptor and insulin signalling in the glomeruli and tubules of the kidney. RECENT
FINDINGS: The insulin receptor is important for podocyte function and when lost results in a number of features resembling diabetic nephropathy. Exciting recent data also highlight the importance of mammalian target of rapamycin in nutrient sensing and protein biosynthesis in the podocyte, which may also be regulated by the insulin receptor. The insulin receptor has also been shown to perform an important role in the distal regions of the renal tubules, regulating sodium excretion and blood pressure control here.
SUMMARY: The insulin receptor is crucial for renal function in glomeruli and tubules. When signalling is diminished here, as may occur in insulin-resistant states, it may be responsible for a number of important renal complications including albuminuric glomerular disease and hypertension.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23104093     DOI: 10.1097/MNH.0b013e32835abb52

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  18 in total

Review 1.  Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.

Authors:  Ralph A DeFronzo; W Brian Reeves; Alaa S Awad
Journal:  Nat Rev Nephrol       Date:  2021-02-05       Impact factor: 28.314

Review 2.  Signal transduction in podocytes--spotlight on receptor tyrosine kinases.

Authors:  Jochen Reiser; Sanja Sever; Christian Faul
Journal:  Nat Rev Nephrol       Date:  2014-01-07       Impact factor: 28.314

Review 3.  The impact of insulin resistance on the kidney and vasculature.

Authors:  Ferruh Artunc; Erwin Schleicher; Cora Weigert; Andreas Fritsche; Norbert Stefan; Hans-Ulrich Häring
Journal:  Nat Rev Nephrol       Date:  2016-10-17       Impact factor: 28.314

4.  Angiotensin II type 2 receptor inhibits expression and function of insulin receptor in rat renal proximal tubule cells.

Authors:  Yang Yang; Caiyu Chen; Chunjiang Fu; Zaicheng Xu; Cong Lan; Yongchun Zeng; Zhi Chen; Pedro A Jose; Ye Zhang; Chunyu Zeng
Journal:  J Am Soc Hypertens       Date:  2017-12-06

5.  IGF-1 and insulin exert opposite actions on ClC-K2 activity in the cortical collecting ducts.

Authors:  Oleg Zaika; Mykola Mamenko; Nabila Boukelmoune; Oleh Pochynyuk
Journal:  Am J Physiol Renal Physiol       Date:  2014-10-22

6.  Cross-talk between insulin and IGF-1 receptors in the cortical collecting duct principal cells: implication for ENaC-mediated Na+ reabsorption.

Authors:  Daria V Ilatovskaya; Vladislav Levchenko; Michael W Brands; Tengis S Pavlov; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-28

Review 7.  New perspective of ClC-Kb/2 Cl- channel physiology in the distal renal tubule.

Authors:  Oleg Zaika; Viktor Tomilin; Mykola Mamenko; Vivek Bhalla; Oleh Pochynyuk
Journal:  Am J Physiol Renal Physiol       Date:  2016-01-20

8.  Insulin and IGF-1 activate Kir4.1/5.1 channels in cortical collecting duct principal cells to control basolateral membrane voltage.

Authors:  Oleg Zaika; Oleg Palygin; Viktor Tomilin; Mykola Mamenko; Alexander Staruschenko; Oleh Pochynyuk
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-02

Review 9.  Paediatrics, insulin resistance and the kidney.

Authors:  Matko Marlais; Richard J Coward
Journal:  Pediatr Nephrol       Date:  2014-07-25       Impact factor: 3.714

Review 10.  NLRP3 Inflammasome in Metabolic-Associated Kidney Diseases: An Update.

Authors:  Wei Xiong; Xian-Fang Meng; Chun Zhang
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.